Regulation of dendrite formation of Purkinje cells by serotonin through serotonin1A and serotonin2A receptors in culture

被引:35
|
作者
Kondoh, M [1 ]
Shiga, T [1 ]
Okado, N [1 ]
机构
[1] Univ Tsukuba, Inst Basic Med Sci, Dept Anat, Tsukuba, Ibaraki 3058575, Japan
关键词
rat; monoamine; development; cerebellum; slice culture;
D O I
10.1016/j.neures.2003.10.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serotonergic fibers and receptors appear in the rat cerebellum during early postnatal development. In the present study, we investigated the actions of serotonin (5-HT) and its receptors in the dendrite formation of Purkinje cells in organotypic cultures of anterior and posterior lobes of the cerebellum at postnatal day 7. In anterior lobes after 4 days in vitro (4DIV), the dendritic areas and branchings of Purkinje cells were increased by the treatment of 2 muM 5-HT, but decreased by 20 muM 5-HT. In posterior lobes after 4DIV, the dendritic areas of Purkinje cells were increased by 5-HT (2, 20 and 200 muM). In contrast, 5-HT treatment decreased dendritic areas of Purkinje cells in both anterior and posterior lobes after 7DIV. Next, we determined the actions of specific 5-HT receptors in mediating the effects of 5-HT by treatment with selective 5-HT receptor agonists. In anterior lobes after 4DIV, dendritic areas of Purkinje cells were increased by a 5-HT1A receptor agonist (8-OH-DPAT), whereas decreased by a 5-HT2A receptor agonist (DOI). The present study suggested that the dendrite formation of Purkinje cells is promoted by 5-HT through 5-HT1A receptors, but inhibited by 5-HT through 5-HT2A receptors. (C) 2003 Elsevier Ireland Ltd and The Japan Neuroscience Society. All rights reserved.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 50 条
  • [11] Serotonin2A receptor-like immunoreactivity in rat cerebellar Purkinje cells
    Maeshima, T
    Shutoh, F
    Hamada, S
    Senzaki, K
    Hamaguchi-Hamada, K
    Ito, R
    Okado, N
    NEUROSCIENCE LETTERS, 1998, 252 (01) : 72 - 74
  • [12] Increased levels of serotonin2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice
    Dean, Brian
    Karl, Tim
    Pavey, Geoffrey
    Boer, Simone
    Duffy, Liesl
    Scarr, Elizabeth
    SCHIZOPHRENIA RESEARCH, 2008, 99 (1-3) : 341 - 349
  • [13] Psychopharmacology of combined activation of the serotonin1A and σ1 receptors
    Ago, Yukio
    Hasebe, Shigeru
    Hiramatsu, Naoki
    Hashimoto, Hitoshi
    Takuma, Kazuhiro
    Matsuda, Toshio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 809 : 172 - 177
  • [14] BRAIN SEROTONIN2 AND SEROTONIN1A RECEPTORS ARE ALTERED IN THE CONGENITALLY HYPERAMMONEMIC SPARSE FUR MOUSE
    ROBINSON, MB
    ANEGAWA, NJ
    GORRY, E
    QURESHI, IA
    COYLE, JT
    LUCKI, I
    BATSHAW, ML
    JOURNAL OF NEUROCHEMISTRY, 1992, 58 (03) : 1016 - 1022
  • [15] The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus
    Bambico, Francis R.
    Duranti, Andrea
    Nobrega, Jose N.
    Gobbi, Gabriella
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (03) : 578 - 590
  • [16] Role of glycosphingolipids in the function of human serotonin1A receptors
    Singh, Pushpendra
    Paila, Yamuna Devi
    Chattopadhyay, Amitabha
    JOURNAL OF NEUROCHEMISTRY, 2012, 123 (05) : 716 - 724
  • [17] Corticosterone regulation of serotonin1A receptors with aging:: Gi protein expression and coupling
    Maines, LW
    Keck, BJ
    Polavarapu, R
    Lakoski, JM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R109 - R109
  • [18] Regulation of serotonin2A receptor expression by an antisense oligodeoxynucleotide
    Scalzitti, JM
    Berg, KA
    Kratowicz, SA
    Hensler, JG
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (04) : 1457 - 1463
  • [19] Regulation of raphe serotonin neurons by serotonin 1A and 2B receptors
    Belmer, Arnauld
    Maroteaux, Luc
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (01) : 218 - 219
  • [20] Regulation of raphe serotonin neurons by serotonin 1A and 2B receptors
    Arnauld Belmer
    Luc Maroteaux
    Neuropsychopharmacology, 2019, 44 : 218 - 219